FINWIRES · TerminalLIVE
FINWIRES

$INMD

8 stories mentioning INMDUpdated 29d ago

Every FINWIRES story that references INMD, newest first.

Sectors

Sector Update: Health Care Stocks Lower Early Monday

Healthcare stocks were mixed in early trading Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) down by 0.2% and the iShares Biotechnology ETF (IBB) 1.4% lower.Moderna (MRNA) shares fell 1.2%, extending the 10.8% loss in the previous session. Jefferies lifted its price target on the company to $60 from $53, while maintaining a hold rating.Madrigal Pharmaceuticals (MDGL) traded down 0.5% after a 4.2% fall at the end of Friday's session. The company said that the US Patent and Trademark Office has issued three new patents covering resmetirom, strengthening its intellectual property portfolio for Rezdiffra.InMode (INMD) stock was down more than 1% after rising 1.8% at the prior close. The company reported preliminary Q2 revenue of $95.2 million to $95.4 million.

$IBB$INMD$MDGL$MRNA$XLV
Sectors

Sector Update: Healthcare

Healthcare stocks were mixed premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) gaining by 0.5% and the iShares Biotechnology ETF (IBB) flat.InMode (INMD) stock was down more than 1% premarket after rising 1.8% at the prior close. The company reported preliminary Q2 revenue of $95.2 million to $95.4 million.

$IBB$INMD$XLV
Commodities

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Renewed US-Iran Conflict Lifts Oil Prices

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.4%, and the actively traded Invesco QQQ Trust (QQQ) retreated 1% in Monday's premarket activity, as renewed military tensions between the US and Iran drove oil prices higher.US stock futures were also lower, with S&P 500 Index futures down 0.3%, Dow Jones Industrial Average futures slipping 0.1%, and Nasdaq futures retreating 0.9% before the start of regular trading.Fed Governor Christopher Waller is slated to speak on Monday.In premarket action, bitcoin was down by 2.1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 1.9% lower, Ether ETF (EETH) retreated 0.7%, and Bitcoin & Ether Market Cap Weight ETF (BETH) gained 2%.Power Play:FinancialThe State Street Financial Select Sector SPDR ETF (XLF) advanced 0.2%. Direxion Daily Financial Bull 3X Shares (FAS) was up 1%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.9% lower.First Hawaiian (FHB) shares traded down 6% in early hours activity, while TriCo Bancshares (TCBK) was up 7% after the companies signed a definitive agreement for First Hawaiian to acquire TriCo in an all-stock transaction.Winners and Losers:TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) retreated 1.5%, and the iShares US Technology ETF (IYW) was 0.4% lower, while the iShares Expanded Tech Sector ETF (IGM) was inactive. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was down 3.2%, while the iShares Semiconductor ETF (SOXX) declined by 3.3%.Intel (INTC) shares were down more than 3% in premarket activity after the company said it is investing 5 billion euros ($5.71 billion) in its Leixlip campus in Ireland to scale capacity to deliver Intel Xeon 6 and next-gen Intel Xeon built on its Intel 3 node.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) was down 0.2%, the Vanguard Industrials Index Fund (VIS) retreated 0.4%, and the iShares US Industrials ETF (IYJ) was inactive.Rockwell Automation (ROK) stock declined more than 3% before the opening bell following a 1% rise at Friday's close. Citigroup lifted the company's price target to $555 from $500 and maintained its buy rating.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.2%, the Vanguard Health Care Index Fund (VHT) was down 0.1%, while the iShares US Healthcare ETF (IYH) was inactive. The iShares Biotechnology ETF (IBB) was 0.4% lower.InMode (INMD) stock was down more than 1% premarket after rising 1.8% at the prior close. The company reported preliminary Q2 revenue of $95.2 million to $95.4 million.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.1%, the Vanguard Consumer Staples Index Fund ETF Shares (VDC) gained 0.1%, and the iShares US Consumer Staples ETF (IYK) was down 0.9%. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) lost 0.1%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.1% lower.Nio (NIO) shares were up more than 1% pre-bell after Goldman Sachs upgraded the company to buy from neutral and lifted its price target to $7 from $6.60.EnergyThe iShares US Energy ETF (IYE) was up 0.5%, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 1.5%.Pembina Pipeline (PBA) stock was up more than 1% before the market open, reversing the 0.8% fall in the prior session. Wells Fargo upgraded Pembina Pipeline to overweight from underweight and raised its price target to CA$76 from CA$55.CommoditiesFront-month US West Texas Intermediate crude oil advanced by 3.8% to $74.09 per barrel on the New York Mercantile Exchange. Natural gas was down by 1.5% to $2.90 per 1 million British Thermal Units. The United States Oil Fund (USO) was up 4%, while the United States Natural Gas Fund (UNG) was 1.4% lower.Gold futures for July fell 1.1% to $4,068.70 an ounce on the Comex. Silver futures retreated by 2.4% to $58.71 an ounce. SPDR Gold Shares (GLD) decreased 1.1%, and the iShares Silver Trust (SLV) was 2.2% lower.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$EEM$EETH$EXI$FAS$FAZ$FHB$GLD$IBB$IGM$IGV$INMD$INTC$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NIO$PBA$PMR$QQQ$ROK$RTH$SLV$SOXX$SPY$TCBK$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Sectors

Sector Update: Healthcare Stocks Advance Premarket Friday

Healthcare stocks were advancing premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) up 0.5%.Mesoblast (MESO) shares were up more than 4% after the company said sales of its steroid-refractory acute graft-versus-host disease treatment, Ryoncil, totaled $36 million in fiscal Q4.SL Science (SLBT) stock was up more than 8% after the company said it has submitted an orphan drug designation request to the US Food and Drug Administration for its Gamma Delta T therapy, named Vdelta2+ Gamma Delta T Cells, for the treatment of glioblastoma multiforme.InMode (INMD) stock was up more than 1% after the company confirmed that its board has received an unsolicited acquisition proposal from Steel Partners Holdings dated July 9.

$IBB$INMD$MESO$SLBT$XLV
Sectors

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index adding 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.9%.The iShares Biotechnology ETF (IBB) climbed 2.4%.In corporate news, Eli Lilly (LLY) and Bayer's pharmaceutical division have backed the Trump administration's call for higher drug prices in Europe, the Financial Times reported. Separately, Lilly said Wednesday it has completed its acquisition of Centessa Pharmaceuticals. Lilly shares were up 0.6%.NRx Pharmaceuticals (NRXP) and two units are facing a lawsuit from Kadima Neuropsychiatry Institute for alleged breach of contract and misrepresentation regarding an acquisition agreement, the psychiatric clinic said Wednesday. NRx Pharmaceuticals shares fell 12%.Pfizer (PFE) has been dismissed as a defendant in a lawsuit brought by 45 US states, the District of Columbia, and 4 US territories that accused drugmakers and executives of fixing generic drug prices, Reuters reported. Its shares were down 2.4%.InMode (INMD) board received an unsolicited acquisition proposal last week for all shares not already owned by M.N. Business Strategy for $16.20 per share in cash, the medical technology firm said Wednesday. The shares jumped 10%.

$INMD$LLY$NRXP$PFE
Sectors

Sector Update: Healthcare Stocks Advance Wednesday Afternoon

Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index adding 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.3%.The iShares Biotechnology ETF (IBB) climbed 2.2%.In corporate news, InMode (INMD) board received an unsolicited acquisition proposal last week for all shares not already owned by M.N. Business Strategy for $16.20 per share in cash, the medical technology firm said Wednesday. Shares jumped 11%.Pfizer (PFE) has been dismissed as a defendant in a lawsuit brought by 45 US states, the District of Columbia, and 4 US territories that accused drugmakers and executives of fixing generic drug prices, Reuters reported. Shares were down 3.1%.Eli Lilly (LLY) and Bayer's pharmaceutical division have backed the Trump administration's call for higher drug prices in Europe, the Financial Times reported. Separately, Lilly said Wednesday it has completed its acquisition of Centessa Pharmaceuticals. Lilly shares were shedding 0.5%.

$INMD$LLY$PFE
Sectors

Sector Update: Healthcare

Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 0.6%.The iShares Biotechnology ETF (IBB) climbed 2.5%.In corporate news, InMode (INMD) board received an unsolicited acquisition proposal last week for all outstanding shares not already owned by M.N. Business Strategy for $16.20 per share in cash, the medical technology company said Wednesday. InMode shares jumped 12%.

$INMD
Wire

InMode Share Fall After Q1 Non-GAAP Earnings Miss Estimates

InMode's (INMD) shares were down more than 6% in Wednesday trading after the company reported Q1 results that missed analyst expectations on earnings and issued a weaker-than-expected 2026 earnings outlook.The company reported Q1 non-GAAP earnings of $0.25 per diluted share, down from $0.31 a year earlier.Analysts polled by FactSet expected $0.29.Revenue for the quarter ended March 31 was $82 million compared with $77.9 million a year earlier.Four analysts surveyed by FactSet expected $80.3 million.The company said it now expects 2026 adjusted EPS in a range of $1.33 to $1.38, down from its previous guidance of $1.43 to $1.48. Analysts surveyed by FactSet expect $1.45.The company maintained its annual revenue guidance of between $365 million and $375 million. Analysts polled by FactSet expect $370 million.Price: $13.38, Change: $-1.02, Percent Change: -7.08%

$INMD

Track with the FINWIRES app suite